Leila Akhvlediani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leila Akhvlediani has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Marina Izmailovich
Department of Internal Medicine, Karaganda Medical University
2 shared publications - Tamila Dilaverova2 shared publications
- A. V. Skvortsova
NPJSC «Karaganda Medical University», Karaganda, Republic of Kazakhstan
1 shared publication - A.A. Dyussupova
НАО «Медицинский университет Cемей», г. Семей, Республика Казахстан
1 shared publication AL-FARABI KAZAKH NATIONAL UNIVERSITY
1 shared publicationAbdullah Kamaluldeen
Department of Biomedical Engineering, Faculty of Materials Engineering, Islamic Azad University, Najafabad branch, Isfahan, Iran
1 shared publication
Latest Publications
- 1 November 2024
- Published by IATED Academy
- Vol. 1, 10810-10816
EFFECTIVENESS OF THE FLIPPED CLASSROOM AND CASE-BASE LEARNING METHODS IN INTEGRATED TEACHING
- 1 November 2024
- Published by IATED Academy
- Vol. 1, 10810-10816
EFFECTIVENESS OF THE FLIPPED CLASSROOM AND CASE-BASE LEARNING METHODS IN INTEGRATED TEACHING
- Open Access
- 1 January 2024
- Published by al-Farabi Kazakh National University in Interdisciplinary Approaches to Medicine
- Vol. 5 (2) , 3-8
MECHANISMS AND CLINICAL PERSPECTIVES OF ALLERGEN-SPECIFIC IMMUNOTHERAPY
Introduction: Allergic rhinitis (AR) is a prevalent condition in Kazakhstan, characterized by high sensitization to weed pollens, particularly Artemisia, with sensitization levels significantly exceeding those observed in Europe. AR often leads to complications such as bronchial asthma (BA) and other respiratory conditions. The “unified airways” concept emphasizes the interconnected nature of upper and lower air-way inflammation, with ASIT showing promise in mitigating these effects.Materials and Methods: A systematic review included 51 articles published between 2013 and 2024, se-lected from databases such as PubMed and Scopus. Studies focused on ASIT in AR and the role of vitamin D. Inclusion criteria required full-text original research and systematic reviews in Russian and English, specifically addressing allergen-specific immunotherapy.Results and Discussion: ASIT promotes immunological tolerance through mechanisms such as suppression of Th2 activity, increased IgG4 production, and reduced effector cell activation. Vitamin D, particularly 25(OH)D, plays a pivotal immunomodulatory role, supporting Treg and Breg cell function, and mitigat-ing allergic inflammation. Clinical trials demonstrate that vitamin D supplementation enhances ASIT out-comes, especially in pediatric patients.Conclusion: Integrating cholecalciferol into ASIT protocols enhances efficacy and safety by addressing vitamin D deficiency, a factor linked to more severe allergic diseases. This highlights the importance of personalized treatment strategies combining ASIT with vitamin D supplementation for optimal outcomes.
- 1 January 2024
- Published by al-Farabi Kazakh National University in Interdisciplinary Approaches to Medicine
- Vol. 5 (2) , 3-8
Open AccessMECHANISMS AND CLINICAL PERSPECTIVES OF ALLERGEN-SPECIFIC IMMUNOTHERAPY
Introduction: Allergic rhinitis (AR) is a prevalent condition in Kazakhstan, characterized by high sensitization to weed pollens, particularly Artemisia, with sensitization levels significantly exceeding those observed in Europe. AR often leads to complications such as bronchial asthma (BA) and other respiratory conditions. The “unified airways” concept emphasizes the interconnected nature of upper and lower air-way inflammation, with ASIT showing promise in mitigating these effects.Materials and Methods: A systematic review included 51 articles published between 2013 and 2024, se-lected from databases such as PubMed and Scopus. Studies focused on ASIT in AR and the role of vitamin D. Inclusion criteria required full-text original research and systematic reviews in Russian and English, specifically addressing allergen-specific immunotherapy.Results and Discussion: ASIT promotes immunological tolerance through mechanisms such as suppression of Th2 activity, increased IgG4 production, and reduced effector cell activation. Vitamin D, particularly 25(OH)D, plays a pivotal immunomodulatory role, supporting Treg and Breg cell function, and mitigat-ing allergic inflammation. Clinical trials demonstrate that vitamin D supplementation enhances ASIT out-comes, especially in pediatric patients.Conclusion: Integrating cholecalciferol into ASIT protocols enhances efficacy and safety by addressing vitamin D deficiency, a factor linked to more severe allergic diseases. This highlights the importance of personalized treatment strategies combining ASIT with vitamin D supplementation for optimal outcomes.
- Open Access
Molecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis
A systematic review and narrative synthesis of publications was undertaken to analyze the role of component-resolved diagnosis technology in identifying polysensitization for the provision of allergen-specific immunotherapy to patients with seasonal allergic rhinitis. A search of publications was carried out in electronic databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search helped to identify 568 publications, 12 of which were included in this review. Overall, 3302 patients were enrolled. The major finding was that component-resolved diagnostics change the choice of relevant allergens for allergen-specific immunotherapy in at least 50% of cases. Sensitization to allergen components differs with age, type of disease, and overall disease duration. Patients who had both bronchial asthma and allergic rhinitis were sensitized to a larger number of allergens than patients who had bronchial asthma alone.
Open AccessMolecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis
A systematic review and narrative synthesis of publications was undertaken to analyze the role of component-resolved diagnosis technology in identifying polysensitization for the provision of allergen-specific immunotherapy to patients with seasonal allergic rhinitis. A search of publications was carried out in electronic databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The search helped to identify 568 publications, 12 of which were included in this review. Overall, 3302 patients were enrolled. The major finding was that component-resolved diagnostics change the choice of relevant allergens for allergen-specific immunotherapy in at least 50% of cases. Sensitization to allergen components differs with age, type of disease, and overall disease duration. Patients who had both bronchial asthma and allergic rhinitis were sensitized to a larger number of allergens than patients who had bronchial asthma alone.
- Open Access
Plasma Polyamines Decrease in Patients with Obstructive Cholecystitis
Polyamines (PAs), endogenous metabolites with a wide range of biological activities, are synthesized at a high rate in liver supporting hepatocyte proliferation and survival. The liver appears as an important regulator of plasma PAs; however, the perspective to exploit plasma PA measurements as indicators for liver function was not explored. This study aimed to evaluate the value of the plasma levels of PAs as a biomarker of pathological changes in the liver in patients with obstructive cholecystitis. The levels of polyamines and their acetylated forms were measured using HPLC/UV in the plasma of patients with obstructive cholecystitis and in healthy subjects. PA turnover was assessed by the ratio between an acetylated form of PA and PA. An effect of diet preference of cheese or meat, the major exogenous sources of PAs, smoking, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in anamnesis was also evaluated in healthy subjects. We found that the plasma levels of spermine and acetylated spermidine decreased in patients with obstructive cholecystitis without a concurring increase in the total plasma bilirubin and amylase levels. The turnover of spermine and spermidine was also changed, suggesting a decrease in the rate of PA degradation in the liver. In healthy subjects, the PA levels tended to mirror chronic smoking and recent SARS-CoV-2 infection but were not relevant to diet factors. A number of observations indicated the role of physical exercise in the regulation of the plasma pool of PA. The decrease in plasma PA levels and index of PA turnover in the cholestasis syndrome indicate the liver’s metabolic function reduction. A conceivable effect of lung-related conditions on plasma PA, while indicating low specificity, nonetheless, speaks favorably about the high sensitivity of plasma PA measurement as an early diagnostic test in the clinic.
Open AccessPlasma Polyamines Decrease in Patients with Obstructive Cholecystitis
Polyamines (PAs), endogenous metabolites with a wide range of biological activities, are synthesized at a high rate in liver supporting hepatocyte proliferation and survival. The liver appears as an important regulator of plasma PAs; however, the perspective to exploit plasma PA measurements as indicators for liver function was not explored. This study aimed to evaluate the value of the plasma levels of PAs as a biomarker of pathological changes in the liver in patients with obstructive cholecystitis. The levels of polyamines and their acetylated forms were measured using HPLC/UV in the plasma of patients with obstructive cholecystitis and in healthy subjects. PA turnover was assessed by the ratio between an acetylated form of PA and PA. An effect of diet preference of cheese or meat, the major exogenous sources of PAs, smoking, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in anamnesis was also evaluated in healthy subjects. We found that the plasma levels of spermine and acetylated spermidine decreased in patients with obstructive cholecystitis without a concurring increase in the total plasma bilirubin and amylase levels. The turnover of spermine and spermidine was also changed, suggesting a decrease in the rate of PA degradation in the liver. In healthy subjects, the PA levels tended to mirror chronic smoking and recent SARS-CoV-2 infection but were not relevant to diet factors. A number of observations indicated the role of physical exercise in the regulation of the plasma pool of PA. The decrease in plasma PA levels and index of PA turnover in the cholestasis syndrome indicate the liver’s metabolic function reduction. A conceivable effect of lung-related conditions on plasma PA, while indicating low specificity, nonetheless, speaks favorably about the high sensitivity of plasma PA measurement as an early diagnostic test in the clinic.
- 1 November 2020
- Published by IATED Academy in ICERI Proceedings
- Vol. 1, 814-820
HOW TO MANAGE PORTFOLIO AND USE IT AS THE BEST TOOL FOR FORMATIVE ASSESSMENT
Information about the paper titled "HOW TO MANAGE PORTFOLIO AND USE IT AS THE BEST TOOL FOR FORMATIVE ASSESSMENT" at IATED Digital Library
- 1 November 2020
- Published by IATED Academy in ICERI Proceedings
- Vol. 1, 814-820
HOW TO MANAGE PORTFOLIO AND USE IT AS THE BEST TOOL FOR FORMATIVE ASSESSMENT
Information about the paper titled "HOW TO MANAGE PORTFOLIO AND USE IT AS THE BEST TOOL FOR FORMATIVE ASSESSMENT" at IATED Digital Library
- 4 October 2019
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (2) , 356-360
Specific Combinations of Erythrocyte Group Antigens in Blood Donors
Blood groups are inherited biological characteristics that do not change throughout life only in healthy people. Blood group antigens determine the adaptation of a human, as a biological species, to the surrounding environment. Our goal was to study the combination and frequency characteristics of three group systems (ABO, RH, KELL) in blood donors. The blood of 743 donors (aged ≥ 18 years) has been investigated on erythrocyte blood group antigens (521 male and 222 female). The sample has been provided from diagnostic laboratory of “Health Centre Medina Ltd” of Batumi. Research was agreed with hematology department of the clinic. Blood typing of the sample has been carried out on the basis of immunogenetic laboratory of Batumi Shota Rustaveli State University. The express method with universal mono-clone antibodies was used in order to reveal blood group system antigens. ABO blood group are distributed the following order: O > A > B > AB. We allocated 16 phenotypic groups. O, Rh+, K− (38.62 ± 1.7%) are represented with the highest percentage among donors and a rather large number of the investigated donors (287 donors) is the carrier of this phenotype. A frequency distribution of the A, Rh+, K− phenotype group 10% (28.93 ± 1.6) was less. 215 donors carry A, Rh+, K− phenotype combination. O, Rh+, K+ and A, Rh+, K+ variations of the phenotype are represented with an equal percentage (3.23 ± 0.4%). 7.94 ± 0.9% donors are characterized by features of the O, Rh−, K− Erythrocyte group. A frequency distribution of B, Rh+, K− phenotype is slightly less − 6.86 ± 0.9%. A, Rh−, K combination of phenotype occurs with a frequency of 4.97 ± 0.7%, and AB, Rh+, K− occurs with a frequency of 2.28 ± 0.5%. I n the donor population there were only single cases of B, Rh−, K+ (0.13 ± 0.01); AB, Rh+, K+ (0.13 ± 0.01); AB, Rh−, K− (0.40 ± 0.2); B, Rh+, K+ (0.26 ± 0.1); O, Rh−, K+ (0.40 ± 0.2); A, Rh−, K+ (0.67 ± 0.2) combination of phenotype. The phenotype AB, Rh−, K+ was not identified. The existence of this database will increase the safety level of transfusion, widen donors database and allow the clinics to find quickly the rare combination of blood group for transfusion and decrease of the risk of post-transfusion complications.
- 4 October 2019
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (2) , 356-360
Specific Combinations of Erythrocyte Group Antigens in Blood Donors
Blood groups are inherited biological characteristics that do not change throughout life only in healthy people. Blood group antigens determine the adaptation of a human, as a biological species, to the surrounding environment. Our goal was to study the combination and frequency characteristics of three group systems (ABO, RH, KELL) in blood donors. The blood of 743 donors (aged ≥ 18 years) has been investigated on erythrocyte blood group antigens (521 male and 222 female). The sample has been provided from diagnostic laboratory of “Health Centre Medina Ltd” of Batumi. Research was agreed with hematology department of the clinic. Blood typing of the sample has been carried out on the basis of immunogenetic laboratory of Batumi Shota Rustaveli State University. The express method with universal mono-clone antibodies was used in order to reveal blood group system antigens. ABO blood group are distributed the following order: O > A > B > AB. We allocated 16 phenotypic groups. O, Rh+, K− (38.62 ± 1.7%) are represented with the highest percentage among donors and a rather large number of the investigated donors (287 donors) is the carrier of this phenotype. A frequency distribution of the A, Rh+, K− phenotype group 10% (28.93 ± 1.6) was less. 215 donors carry A, Rh+, K− phenotype combination. O, Rh+, K+ and A, Rh+, K+ variations of the phenotype are represented with an equal percentage (3.23 ± 0.4%). 7.94 ± 0.9% donors are characterized by features of the O, Rh−, K− Erythrocyte group. A frequency distribution of B, Rh+, K− phenotype is slightly less − 6.86 ± 0.9%. A, Rh−, K combination of phenotype occurs with a frequency of 4.97 ± 0.7%, and AB, Rh+, K− occurs with a frequency of 2.28 ± 0.5%. I n the donor population there were only single cases of B, Rh−, K+ (0.13 ± 0.01); AB, Rh+, K+ (0.13 ± 0.01); AB, Rh−, K− (0.40 ± 0.2); B, Rh+, K+ (0.26 ± 0.1); O, Rh−, K+ (0.40 ± 0.2); A, Rh−, K+ (0.67 ± 0.2) combination of phenotype. The phenotype AB, Rh−, K+ was not identified. The existence of this database will increase the safety level of transfusion, widen donors database and allow the clinics to find quickly the rare combination of blood group for transfusion and decrease of the risk of post-transfusion complications.